Mozart is developing CD8 Treg cell modulators for the treatment of autoimmune and inflammatory diseases.Our advancing pipeline of first-in-class ‘CD8 Treg cell modulators’ are designed to restore durable immune balance and avert the progressive damage caused by pathogenic immune responses.
To date, we’ve demonstrated that CD8 T regulatory cells are selective and function specifically to eliminate pathogenic CD4 T cells ...
Mozart is developing CD8 Treg cell modulators for the treatment of autoimmune and inflammatory diseases.Our advancing pipeline of first-in-class ‘CD8 Treg cell modulators’ are designed to restore durable immune balance and avert the progressive damage caused by pathogenic immune responses.
To date, we’ve demonstrated that CD8 T regulatory cells are selective and function specifically to eliminate pathogenic CD4 T cells and other pathogenic immune cells. The dysregulation of this T cell network is a root cause for the onset and severity of autoimmune and inflammatory disease and pathology.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.